GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway

  • Authors:
    • Haixia Hu
    • Zuanfang Li
    • Xiaoqin Zhu
    • Ruhui Lin
    • Jun Peng
    • Jing Tao
    • Lidian Chen
  • View Affiliations

  • Published online on: October 11, 2013     https://doi.org/10.3892/ijmm.2013.1522
  • Pages: 1281-1286
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Microglial activation plays an important role in neroinflammation following ischemic stroke. Activated microglial cells can then migrate to the site of injury to proliferate and release substances which induce secondary brain damage. It has been shown that microglial migration is associated with the activation of the mitogen-activated protein kinase (MAPK) signaling pathways. The Chinese formula, GuaLou GuiZhi decoction (GLGZD), has long been administered in clinical practice for the treatment of post-stroke disabilities, such as muscular spasticity. In a previous study, we demonstrated that the anti-inflammtory effects of GLGZD were mediated by the TLR4/NF-κB pathway in lipopolysaccharide (LPS)-stimulated microglial cells. Therefore, in this study, we evaluated the role of GLGZD in microglial migration by performing scratch wound assays and migration assays. We wished to elucidate the cellular and molecular mechanisms elicited by this TCM formula in microglial-induced inflammation by evaluating the release and expression of chemotactic cytokines [monocyte chemo­attractant protein-1 (MCP-1), macrophage inflammatory protein-1α (MIP-1α) and interleukin (IL)-8] by ELISA and quantitative PCR. Our results revealed that the migration of microglial cells was enhanced in the presence of LPS (100 ng/ml); however, GLGZD (100 µg/ml) significantly inhibited cell motility and the production of chemokines through the inhibition of the activation of the p38 and c-Jun N-terminal protein kinase (JNK) signaling pathway. We demonstrate the potential of GLGZD in the modulation of microglial motility by investigating the effects of GLGZD on microglial migration induced by LPS. Taken together, our data suggest that GLGZD per se cannot trigger microglial motility, whereas GLGZD impedes LPS-induced microglial migration through the activation of the MAPK signaling pathway. These results provide further evidence of the anti-inflammatory effects of GLGZD and its potential for use in the treatment of ischemic stroke.
View Figures
View References

Related Articles

Journal Cover

December 2013
Volume 32 Issue 6

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hu H, Li Z, Zhu X, Lin R, Peng J, Tao J and Chen L: GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway. Int J Mol Med 32: 1281-1286, 2013.
APA
Hu, H., Li, Z., Zhu, X., Lin, R., Peng, J., Tao, J., & Chen, L. (2013). GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway. International Journal of Molecular Medicine, 32, 1281-1286. https://doi.org/10.3892/ijmm.2013.1522
MLA
Hu, H., Li, Z., Zhu, X., Lin, R., Peng, J., Tao, J., Chen, L."GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway". International Journal of Molecular Medicine 32.6 (2013): 1281-1286.
Chicago
Hu, H., Li, Z., Zhu, X., Lin, R., Peng, J., Tao, J., Chen, L."GuaLou GuiZhi decoction inhibits LPS-induced microglial cell motility through the MAPK signaling pathway". International Journal of Molecular Medicine 32, no. 6 (2013): 1281-1286. https://doi.org/10.3892/ijmm.2013.1522